- Supported exchanges /
- F /
- 6T40.F
TREVENA INC. DL-001 (6T40 F) stock market data APIs
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.
TREVENA INC. DL-001 Financial Data Overview
| 3.825 | |
| 3.825 | |
| - | |
| 3.825 | |
| 3.825 | |
| 0.1446-4.15 | |
| 120 K | |
| 734 K | |
| 443 K | |
| 1.051 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
TREVENA INC. DL-001 Fundamental Data is available in our Financial Data APIs
- Net Revenue 443 K
- EBITDA -35 009 000
- Earnings Per Share -51.67
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get TREVENA INC. DL-001 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get TREVENA INC. DL-001 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
